Cancer drug company Tesaro shares rise 39% following report that it will explore sale

Learn anything. Thousands of top courses to choose from.
Health, Fitness & Food

Tesaro shares soared 39 percent Friday upon a Bloomberg report that the pharmaceutical company will explore the opportunity of a sale.

This comes exactly one week after Tesaro fell more than 20 percent during after-hours trading after the release of drug trial results. A spokesperson declined to comment.

This story is developing. Please check back for updates.

Articles You May Like

This Dietitian’s TikTok Breaks Down the Steps to Making the Perfect Satisfying Snack
Young Woman’s Breast Cancer Diagnosis Ends Up Saving Her Mom’s Life 2 Years Later
Immersive VR can disrupt children’s default coordination strategy
‘The View’ pulls 2 hosts off the air over positive Covid tests, minutes before interview with Vice President Harris
Early Endoscopy for Acute GI Bleeds Tied to Better Outcomes

Leave a Reply

Your email address will not be published. Required fields are marked *